Shockwave Medical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Shockwave Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10461
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of advanced cardiovascular diseases. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology which built on balloon catheter platform for the treatment of calcified plaque. Its treatment portfolio includes surgical bypass, angioplasty, stenting, and atherectomy. In addition, the company also involved in treating peripheral artery disease which occurs primarily in legs and in vessels throughout the body. Shockwave is headquartered in Fremont, California, the US.

Shockwave Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shockwave Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shockwave Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Shockwave Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shockwave Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Shockwave Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shockwave Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Shockwave Medical Raises Additional USD35 Million in Series C Financing 10
Shockwave Medical Raises USD45 Million in Series C Financing 11
Shockwave Medical Raises USD40 Million in Venture Financing 13
Shockwave Medical Raises US$12.5 Million In Series A Financing Round 15
Shockwave Medical Inc – Key Competitors 16
Shockwave Medical Inc – Key Employees 17
Shockwave Medical Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
May 10, 2017: Shockwave Medical Appoints Doug Godshall as President and CEO 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Shockwave Medical Inc, Medical Equipment, Key Facts 2
Shockwave Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Shockwave Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shockwave Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Shockwave Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shockwave Medical Inc, Deals By Market, 2012 to YTD 2018 8
Shockwave Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shockwave Medical Raises Additional USD35 Million in Series C Financing 10
Shockwave Medical Raises USD45 Million in Series C Financing 11
Shockwave Medical Raises USD40 Million in Venture Financing 13
Shockwave Medical Raises US$12.5 Million In Series A Financing Round 15
Shockwave Medical Inc, Key Competitors 16
Shockwave Medical Inc, Key Employees 17
Shockwave Medical Inc, Other Locations 18

List of Figures
Shockwave Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Shockwave Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Shockwave Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Shockwave Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Shockwave Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Shockwave Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Shockwave Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Shockwave Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Shockwave Medical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Agios Pharmaceuticals Inc (AGIO):医療機器:M&Aディール及び事業提携情報
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Chesapeake Lodging Trust:企業のM&A・事業提携・投資動向
    Chesapeake Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chesapeake Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Kingsgate Consolidated Limited:企業の戦略・SWOT・財務情報
    Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report Summary Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …
  • Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 …
  • Aprea AB-製薬・医療分野:企業M&A・提携分析
    Summary Aprea AB (Aprea) discovers and develops novel anticancer compounds targeting the tumor suppressor protein p53. The company’s lead drug candidate includes APR-246, an anti-cancer compound that targets and reactivates the tumor suppressor protein p53, inducing programmed cell death in many hum …
  • Dunmore Corporation:企業の戦略的SWOT分析
    Dunmore Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Lego AS:企業の戦略的SWOT分析
    Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • FactSet Research Systems Inc. (FDS):企業の財務・戦略的SWOT分析
    FactSet Research Systems Inc. (FDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Quebecor Inc (QBR.B):企業の財務・戦略的SWOT分析
    Quebecor Inc (QBR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Falco SD Holdings Co Ltd (4671):企業の財務・戦略的SWOT分析
    Summary Falco SD Holdings Co Ltd (Falco), formerly Falco Biosystems Ltd is a clinical testing and dispensing pharmacy service provider. The company offers services such as genetic testing, clinical trials, medical information systems development, and food sanitation and environmental testing. It pro …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • Manulife Financial Corporation:戦略・SWOT・企業財務分析
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • University of New Mexico-製薬・医療分野:企業M&A・提携分析
    Summary University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin America …
  • Denso Corporation:企業の戦略・SWOT・財務分析
    Denso Corporation - Strategy, SWOT and Corporate Finance Report Summary Denso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Otto GmbH & Co KG:企業の戦略・SWOT・財務情報
    Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AC Immune SA (ACIU):製薬・医療:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆